5giy
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==HSA-Palmitic acid-[RuCl5(ind)]2-== | |
| - | + | <StructureSection load='5giy' size='340' side='right' caption='[[5giy]], [[Resolution|resolution]] 2.54Å' scene=''> | |
| - | + | == Structural highlights == | |
| - | + | <table><tr><td colspan='2'>[[5giy]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5GIY OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5GIY FirstGlance]. <br> | |
| - | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=7GE:pentakis(chloranyl)-(1~{H}-indazol-2-ium-2-yl)ruthenium(1-)'>7GE</scene>, <scene name='pdbligand=PLM:PALMITIC+ACID'>PLM</scene></td></tr> | |
| - | [[Category: | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5giy FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5giy OCA], [http://pdbe.org/5giy PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5giy RCSB], [http://www.ebi.ac.uk/pdbsum/5giy PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5giy ProSAT]</span></td></tr> |
| + | </table> | ||
| + | == Disease == | ||
| + | [[http://www.uniprot.org/uniprot/ALBU_HUMAN ALBU_HUMAN]] Defects in ALB are a cause of familial dysalbuminemic hyperthyroxinemia (FDH) [MIM:[http://omim.org/entry/103600 103600]]. FDH is a form of euthyroid hyperthyroxinemia that is due to increased affinity of ALB for T(4). It is the most common cause of inherited euthyroid hyperthyroxinemia in Caucasian population.<ref>PMID:8048949</ref> <ref>PMID:7852505</ref> <ref>PMID:9329347</ref> <ref>PMID:9589637</ref> | ||
| + | == Function == | ||
| + | [[http://www.uniprot.org/uniprot/ALBU_HUMAN ALBU_HUMAN]] Serum albumin, the main protein of plasma, has a good binding capacity for water, Ca(2+), Na(+), K(+), fatty acids, hormones, bilirubin and drugs. Its main function is the regulation of the colloidal osmotic pressure of blood. Major zinc transporter in plasma, typically binds about 80% of all plasma zinc.<ref>PMID:19021548</ref> | ||
| + | == References == | ||
| + | <references/> | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Wang, T]] | ||
[[Category: Yang, F]] | [[Category: Yang, F]] | ||
| - | [[Category: | + | [[Category: Anticancer activity]] |
| + | [[Category: Drug delivery system]] | ||
| + | [[Category: Human serum albumin]] | ||
| + | [[Category: Interactions of protein-ligand]] | ||
| + | [[Category: Peptide binding protein]] | ||
| + | [[Category: Ruthenium-based drug]] | ||
Revision as of 15:58, 20 October 2017
HSA-Palmitic acid-[RuCl5(ind)]2-
| |||||||||||
